CapEx
McKesson CapEx decreased by 47.6% to $111.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.7%, from $106.00M to $111.00M. Over 3 years (FY 2022 to FY 2025), CapEx shows an upward trend with a 11.4% CAGR.
Analysis
How to read this metric
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
Detailed definition
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Peer comparison
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expendituresHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $93.00M | $64.00M | $108.00M | $123.00M | $71.00M | $82.00M | $90.00M | $147.00M | $78.00M | $164.00M | $126.00M | $63.00M | $106.00M | $111.00M | $108.00M | $212.00M | $111.00M |
| QoQ Change | — | -31.2% | +68.8% | +13.9% | -42.3% | +15.5% | +9.8% | +63.3% | -46.9% | +110.3% | -23.2% | -50.0% | +68.3% | +4.7% | -2.7% | +96.3% | -47.6% |
| YoY Change | — | — | — | — | -23.7% | +28.1% | -16.7% | +19.5% | +9.9% | +100.0% | +40.0% | -57.1% | +35.9% | -32.3% | -14.3% | +236.5% | +4.7% |
Business Segments
| Segment | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| U.S. Pharmaceutical | $38.50M | $38.50M | $48.25M | $48.25M | $48.25M | $48.25M | $28.00M | $73.00M |
| Medical-Surgical Solutions | $29.25M | $29.25M | $39.75M | $39.75M | $39.75M | $39.75M | $51.00M | $25.00M |
| International | $19.75M | $19.75M | $18.75M | $18.75M | $18.75M | $18.75M | $25.00M | $13.00M |
| Total | $90.00M | $147.00M | $78.00M | $164.00M | $126.00M | $63.00M | $106.00M | $111.00M |
International, Medical-Surgical Solutions, U.S. Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
CapEx at Other Companies
Frequently Asked Questions
- What is McKesson's capex?
- McKesson (MCK) reported capex of $111.00M in Q2 2025.
- How has McKesson's capex changed year-over-year?
- McKesson's capex increased by 4.7% year-over-year, from $106.00M to $111.00M.
- What is the long-term trend for McKesson's capex?
- Over 3 years (2022 to 2025), McKesson's capex has grown at a 11.4% compound annual growth rate (CAGR), from $388.00M to $537.00M.
- What does capex mean?
- Cash spent on purchasing or maintaining physical assets like machinery and facilities.